These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20230546)

  • 61. Setting Dead at Zero: Applying Scale Properties to the QALY Model.
    Roudijk B; Donders ART; Stalmeier PFM
    Med Decis Making; 2018 Aug; 38(6):627-634. PubMed ID: 29629848
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Use of Health State Utility Values in Decision Models.
    Ara R; Brazier J; Zouraq IA
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):77-88. PubMed ID: 29052163
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Estimated quality-adjusted life-year associated with the degree of activities of daily living in patients with Alzheimer's disease.
    Kasai M; Meguro K
    Dement Geriatr Cogn Dis Extra; 2013 Jan; 3(1):482-8. PubMed ID: 24516416
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Retaining, and enhancing, the QALY.
    Lipscomb J; Drummond M; Fryback D; Gold M; Revicki D
    Value Health; 2009 Mar; 12 Suppl 1():S18-26. PubMed ID: 19250127
    [No Abstract]   [Full Text] [Related]  

  • 65. Quality-adjusted life years: population-specific measurement of the quality component.
    McGhee SM; Brazier J; Lam CL; Wong LC; Chau J; Cheung A; Ho A
    Hong Kong Med J; 2011 Dec; 17 Suppl 6():17-21. PubMed ID: 22147354
    [No Abstract]   [Full Text] [Related]  

  • 66. Validation of the predictive accuracy of health-state utility values based on the Lloyd model for metastatic or recurrent breast cancer in Japan.
    Iwatani T; Inoue E; Tsugawa K
    BMJ Open; 2021 Dec; 11(12):e046273. PubMed ID: 34853098
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparing the incomparable? A systematic review of competing techniques for converting descriptive measures of health status into QALY-weights.
    Mortimer D; Segal L
    Med Decis Making; 2008; 28(1):66-89. PubMed ID: 18263562
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A test of the QALY model when health varies over time.
    Spencer A
    Soc Sci Med; 2003 Nov; 57(9):1697-706. PubMed ID: 12948578
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A fallacy of the multiplicative QALY model for low-quality weights in students and patients judging hypothetical health states.
    Stalmeier PF; Chapman GB; de Boer AG; van Lanschot JJ
    Int J Technol Assess Health Care; 2001; 17(4):488-96. PubMed ID: 11758293
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Eliciting stated health preferences: an application to willingness to pay for longevity.
    Johnson FR; Desvousges WH; Ruby MC; Stieb D; De Civita P
    Med Decis Making; 1998; 18(2 Suppl):S57-67. PubMed ID: 9566467
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Heath State Utility Values for Cost-Effectiveness Models.
    Karnon J
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):1-3. PubMed ID: 29052154
    [No Abstract]   [Full Text] [Related]  

  • 72. Exponential health utility. A characterization and comments on the contribution by Happich and Muhlbacher.
    Osterdal LP
    Eur J Health Econ; 2004 Dec; 5(4):365-7. PubMed ID: 15549604
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The measurement of utility in multiphase health states.
    Richardson J; Hall J; Salkeld G
    Int J Technol Assess Health Care; 1996; 12(1):151-62. PubMed ID: 8690556
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sourcing and Using Appropriate Health State Utility Values in Economic Models in Health Care.
    Ara R; Peasgood T; Mukuria C; Chevrou-Severac H; Rowen D; Azzabi-Zouraq I; Paisley S; Young T; van Hout B; Brazier J
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):7-9. PubMed ID: 29052161
    [No Abstract]   [Full Text] [Related]  

  • 75. A different approach to health state valuation.
    Value Health; 2009 Mar; 12 Suppl 1():S16-7. PubMed ID: 19250126
    [No Abstract]   [Full Text] [Related]  

  • 76. Quality-Adjusted Life Years (QALY) Utility Models under Expected Utility and Rank Dependent Utility Assumptions.
    Miyamoto JM
    J Math Psychol; 1999 Jun; 43(2):201-237. PubMed ID: 10366516
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Use of Mapping to Estimate Health State Utility Values.
    Ara R; Rowen D; Mukuria C
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):57-66. PubMed ID: 29052160
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Selection of Appropriate Health State Utility Values (Hsuvs) for Health Technology Assessment (Hta): Lessons To Be Learnt.
    Patel A; King D; Greenall G; Mitchell SA; Purushotham S; Hudson PM
    Value Health; 2014 Nov; 17(7):A573. PubMed ID: 27201917
    [No Abstract]   [Full Text] [Related]  

  • 79. Using health state utility values from the general population to approximate baselines in decision analytic models when condition-specific data are not available.
    Ara R; Brazier JE
    Value Health; 2011 Jun; 14(4):539-45. PubMed ID: 21669378
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Catalogue of EQ-5D scores for the United Kingdom.
    Sullivan PW; Slejko JF; Sculpher MJ; Ghushchyan V
    Med Decis Making; 2011; 31(6):800-4. PubMed ID: 21422468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.